Istanbul, Turkey

Metin Turkay

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Koç Üniversitesi. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Metin Turkay. Retrieved from https://idiyas.com/inventor/metin-turkay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Metin Turkay: Innovator in Circadian Rhythm Research

Introduction

Metin Turkay is a prominent inventor based in Istanbul, Turkey. He has made significant contributions to the field of circadian rhythm research. His innovative work focuses on developing treatments for circadian rhythm diseases and disorders.

Latest Patents

Metin Turkay holds a patent for a groundbreaking invention titled "2-[2-({12,12-DIMETHYL-4-OXO-6-PHENYL-3,11-DIOXATRICYCLO[8.4.0.0,2,7]TETRADECA-1,5,7,9-TETRAEN-8-YL}OXY)ACETAMIDO]BENZAMIDE AND DERIVATIVES AS INHIBITOR OF CLOCK:BMAL1 INTERACTION FOR THE TREATMENT OF CIRCADIAN RHYTHM DISEASES AND DISORDERS." This patent represents a significant advancement in the treatment of circadian rhythm-related conditions.

Career Highlights

Metin Turkay is affiliated with Koç Üniversitesi, where he conducts research and develops innovative solutions in his field. His work has garnered attention for its potential impact on health and well-being.

Collaborations

Throughout his career, Metin has collaborated with notable colleagues, including Ibrahim Halil Kavakli and Yagmur Umay Doruk. These collaborations have further enriched his research and contributed to advancements in circadian rhythm studies.

Conclusion

Metin Turkay is a dedicated inventor whose work in circadian rhythm research is paving the way for new treatments. His innovative patent and collaborations highlight his commitment to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…